This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Deana Demjen: Innovator in Neurological Treatments
Introduction
Deana Demjen is a prominent inventor based in Heidelberg, Germany. She has made significant contributions to the field of neurological disorders through her innovative research and patenting efforts. Her work focuses on the treatment of spinal cord injuries and related conditions.
Latest Patents
Deana Demjen holds a patent for the "Inhibition of the CD95 ligand/receptor system for the treatment of neurological disorders and injuries." This invention relates to the use of inhibitors of the CD95 ligand/receptor system for the manufacture of a medicament aimed at treating neurological disorders or injuries in mammals, particularly spinal cord injuries and paraplegia. She has 1 patent to her name.
Career Highlights
Throughout her career, Deana has worked with esteemed institutions, including the Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts. Her research has been pivotal in advancing the understanding and treatment of neurological conditions.
Collaborations
Deana has collaborated with notable colleagues such as Ana Martin-Villalba and Peter Krammer, contributing to a rich exchange of ideas and research in her field.
Conclusion
Deana Demjen's innovative work in the treatment of neurological disorders showcases her dedication to improving medical outcomes for patients. Her contributions continue to influence the field and inspire future research.